Skip to main content
. 2021 Aug 6;2021:5572129. doi: 10.1155/2021/5572129

Figure 1.

Figure 1

Prion peptide 106-126 aggregation status. (a) Neuroblastoma cells (SK-N-SH) were pretreated with 20 μM ThT for 30 min and then exposed to 25, 50, and 100 μM PrP 106-126, 100 μM sc-PrP, or 100 μM amyloid β for 6 h. (b) Fluorescence was evaluated by spectrum analysis and fluorescence microscopy.